
AlphaTON Capital Corp.
AlphaTON Capital Corp. (ATON) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · ATON · as of Jun 8, 2026
Key Statistics
Explore AlphaTON Capital Corp. Data
aton stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 4 · Buy rate: 100.0%
The ATON analyst consensus is Buy, based on ratings from 4 Wall Street analysts over the past 3 months. The average 12-month price target is $4.88, representing +1722.94% upside from the current price of $0.27.
Competitors & Peers
aton competitorsStock Performance
Full HistoryAbout AlphaTON Capital Corp.
AlphaTON Capital Corp. is the rebranded entity formerly known as Portage Biotech Inc., a clinical-stage immuno-oncology company transitioning into a digital asset treasury model focused on accumulatin…
what is alphaton capital corp. · aton stock overview · alphaton capital corp. company profile · who is alphaton capital corp. ceo · aton NASDAQ · alphaton capital corp. headquarters · alphaton capital corp. business segments
About Stock Overview & Key Data
AlphaTON Capital Corp. (ATON) is a Financial Services company in the Asset Management industry, listed on NASDAQ since Jan 2, 2002. As of the latest trading session, ATON stock price is $0.27, with a market capitalization of $609,903. The stock has returned -96.48% over the past 12 months and -55.45% year-to-date.
According to 4 Wall Street analysts, the consensus rating for AlphaTON Capital Corp. stock is Buy, with an average 12-month price target of $4.88. In fiscal year 2025, AlphaTON Capital Corp. reported revenue of — and net income of -$6.8M. For detailed data — including AlphaTON Capital Corp. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, AlphaTON Capital Corp. (ATON) stock price is $0.27. The stock is traded on NASDAQ under the ticker symbol ATON. The 52-week range is $0.18 – $13.80.